Wes Brazell is a seasoned financial executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Chief Financial Officer at PolyActiva since June 2025, Wes has previously held the CFO position at Xequel Bio from February 2022 to May 2025, Eyevance Pharmaceuticals from April 2018 to January 2022, and ScoutPro Osmolarity System from July 2015 to March 2018. Additionally, Wes was the CFO at Academic Partnerships from March 2014 to June 2015 and held significant roles at Alcon, including Head of Global Business Planning and Analysis and Regional CFO for Europe, the Middle East, and Africa from January 2010 to March 2014. Wes Brazell earned a degree from Baylor University's Hankamer School of Business between 1984 and 1988.
This person is not in the org chart
This person is not in any teams
This person is not in any offices